You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aprepitant

Showing 1 - 25 of 207
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Nausea and Vomiting, Postoperative Trial in Mexico City (Aprepitant, Placebo)

Active, not recruiting
  • Obesity
  • Nausea and Vomiting, Postoperative
  • Aprepitant
  • Placebo
  • Mexico City, Mexico
    Hospital General Tlahuac
Mar 6, 2023

Hepatocellular Carcinoma Trial (Aprepitant in combination with granisetron and dexamethasone, Granisetron and dexamethasone)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Aprepitant in combination with granisetron and dexamethasone
  • Granisetron and dexamethasone
  • (no location specified)
Feb 2, 2023

Breast Cancer Trial in Shanghai (Aprepitant, Mirtazapine)

Completed
  • Breast Cancer
  • Shanghai, China
    Fudan University Cancer Hospital
Apr 19, 2022

Determining Clinical Relevance of inTeraction Between AprepitaNt

Completed
  • Testicular Cancer
  • Blood sampling - Pharmacokinetic assessment
  • Nijmegen, Netherlands
    Radboud UMC
Sep 9, 2022

Postoperative Nausea, Vomiting Trial in Ankara (Aprepitant, Granisetron)

Not yet recruiting
  • Postoperative Nausea
  • Vomiting
  • Ankara, Turkey
    Baskent University Ankara Hospital
Nov 18, 2022

Chemo-induced Nausea and Vomiting Trial in Toronto (Aprepitant Capsule 125 MG, Aprepitant oral suspension 20 mg/mL)

Completed
  • Chemotherapy-induced Nausea and Vomiting
  • Aprepitant Capsule 125 MG
  • Aprepitant oral suspension 20 mg/mL
  • Toronto, Ontario, Canada
    Hospital for Sick Children
Apr 1, 2022

Postoperative Nausea and Vomiting, Bariatric Surgery Trial in Bern (Aprepitant 80 mg, Placebo)

Recruiting
  • Postoperative Nausea and Vomiting
  • Bariatric Surgery
  • Aprepitant 80 mg
  • Placebo
  • Bern, Switzerland
    Department of Anaesthesiology and Pain Medicine, Bern University
Mar 17, 2022

Heart Failure Trial in New Haven (LCZ 696, Placebo, Para-aminohippurate)

Recruiting
  • Heart Failure
  • LCZ 696
  • +4 more
  • New Haven, Connecticut
    Yale New Haven Hospital
Dec 27, 2022

Pruritus Trial in Berlin (Aprepitant, Placebo)

Completed
Has Results
  • Pruritus
  • Aprepitant
  • Placebo
  • Berlin, Germany
    Allergie-Zentrum-Charité, Charité - Universitätsmedizin Berlin
Jun 28, 2021

Gynecological Tumor Trial in Chengdu (Aprepitant Injection)

Not yet recruiting
  • Gynecological Tumor
  • Aprepitant Injection
  • Chengdu, Sichua, China
    Dengfeng Wang
Aug 22, 2023

Nausea With Vomiting Chemo-Induced Trial in Wuhan (Ondansetron every 3 weeks, Aprepitant, Dexamethasone)

Not yet recruiting
  • Nausea With Vomiting Chemotherapy-Induced
  • Ondansetron every 3 weeks
  • +3 more
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Oct 8, 2023

Opioid Dependence Trial in New York (Aprepitant, Placebo pill)

Completed
  • Opioid Dependence
  • Aprepitant
  • Placebo pill
  • New York, New York
    Bellevue Hospital Center & the NYU School of Medicine
Aug 17, 2021

Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy-induced Nausea and Vomiting
  • Aprepitant
  • +2 more
  • Hanzhou, Zhejiang, China
    the Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023

Chemo-induced Nausea and Vomiting, Colorectal Cancer Trial in Guangzhou (Aprepitant+Tropisetron, Dexamethasone+Tropisetron)

Completed
  • Chemotherapy-induced Nausea and Vomiting
  • Colorectal Cancer
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Jul 24, 2021

Chemo-induced Nausea and Vomiting Trial in Moscow (Ondansetron, Dexamethasone, Aprepitant)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Moscow, Russian Federation
    Zhukov Nikolay
Jul 27, 2022

NSCLC Trial in GuangZhou (Aprepitant, Desloratadine, Placebo of aprepitant)

Completed
  • Non-small Cell Lung Cancer
  • Aprepitant
  • +3 more
  • GuangZhou, Guangdong, China
    Cancer Center of Sun-Yat Sen University (CCSYSU)
May 15, 2021

Nausea, Vomiting, Childhood Cancer Trial in Oklahoma City (Ondansetron, dexamethasone, aprepitant, Ondansetron, Dexamethasone, )

Completed
  • Nausea
  • +2 more
  • Ondansetron, dexamethasone, aprepitant
  • Ondansetron, Dexamethasone, placebo
  • Oklahoma City, Oklahoma
    Jimmy Everest Center for Cancer and Blood Disorders in Children
Mar 18, 2021

Myeloproliferative Disorder, Aquagenic Pruritus Trial in France (Aprepitant 80 mg, Hydroxyzine 25mg, Placebo of Hydroxyzine)

Recruiting
  • Myeloproliferative Disorder
  • Aquagenic Pruritus
  • Aprepitant 80 mg
  • +3 more
  • Brest, Brest Cedex, France
  • +10 more
Jun 10, 2021

Chemo Induced Nausea and Vomiting, Pediatric Cancer Patients Trial in Shanghai (fosaprepitant, aprepitant, Granisetron plus

Not yet recruiting
  • Chemotherapy Induced Nausea and Vomiting
  • Pediatric Cancer Patients
  • Shanghai, China
    Shanghai Children's Medical Center
May 5, 2021

Nausea, Vomiting, Head and Neck Squamous Cell Carcinoma Trial in Beijing (Olanzapine)

Recruiting
  • Nausea
  • +3 more
  • Beijing, Beijing, China
    Ye Zhang
Jan 8, 2022

Perioperative Optimization Trial in Pittsburgh (dietary supplement, drug, other)

Not yet recruiting
  • Perioperative Optimization
  • Neuraxial Analgesia
  • +11 more
  • Pittsburgh, Pennsylvania
  • +3 more
Jan 4, 2023

Breast Cancer Trial in Hong Kong (Experimental drug: Aprepitant, Experimental drug: Ondansetron, Experimental drug:

Completed
  • Breast Cancer
  • Experimental drug: Aprepitant
  • +6 more
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital
Jul 26, 2021

Type 2 Diabetes, Hypertension Trial in Nashville (Placebo, Sitagliptin, Aprepitant)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Hypertension
  • Placebo
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University
Feb 8, 2022

Soft Tissue Sarcoma Trial in Bordeaux, Montpellier, Toulouse (Patients starting a treatment with Doxorubicin and Ifosfamide)

Completed
  • Soft Tissue Sarcoma
  • Patients starting a treatment with Doxorubicin and Ifosfamide
  • Bordeaux, France
  • +2 more
Jan 11, 2021

Post-operative Nausea and Vomiting, Laparoscopic Sleeve Gastrectomy Trial in Stony Brook (Aprepitant 80Mg Oral Capsule,

Completed
  • Post-operative Nausea and Vomiting
  • Laparoscopic Sleeve Gastrectomy
  • Aprepitant 80Mg Oral Capsule
  • +12 more
  • Stony Brook, New York
    Stony Brook University Hospital
Mar 11, 2022